SECTORS TODAY
Tech XLK -4.89%
Financials XLF -0.76%
Healthcare XLV +0.45%
Energy XLE +1.91%
Industrials XLI -1.60%
Cons. Disc. XLY -0.71%
Cons. Staples XLP +1.41%
Utilities XLU +0.67%
Materials XLB +0.40%
Real Estate XLRE +0.26%
Comm. Svcs XLC -1.29%

Earnings release · TSN

TYSON FOODS REPORTS THIRD QUARTER 2026 RESULTS

Tyson Foods, Inc. · Filed · SEC Form 8-K, Item 2.02

Tyson Foods, Inc. company page Original on SEC.gov ↗

Revenue $41,834 million +3.1% vs a year ago
EPS $1.49 +24% vs a year ago
Guidance revisedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete. Please read the original before relying on any figure. Not investment advice.

Why it matters

Revenue increased 3.1% year on year to $41,834 million, and EPS climbed 24% to $1.49. Growth in both sales and earnings is the combination investors usually look for first. The company revised its guidance; the original release shows which items moved and by how much.

Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.

What the company states

Revenue

$41,834 million +3.1% vs a year ago

…Sales of $41,834 million, up 3.1% from prior year; Sales up 2.8% excluding the impact of legal contingency accrua…
EPS

$1.49 +24% vs a year ago

…GAAP EPS of $1.49, up 24% from prior year…
Guidance

Guidance revised

…The following is a summary of the updated outlook for each of our segments, as well as an outlook for corporate expenses and amortization, revenue, capital expenditures, net interest expense, liq…

Read the original press release on SEC.gov ↗ Filing index ↗

Trend: last 1 reports

All releases →

Revenue growth (YoY)

EPS growth (YoY)

Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.

Get new research in your inbox

Forensic equity research on US stocks. No spam, unsubscribe anytime.